Isoquinoline and benzo[H] isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine H3 receptor
US7678807B2 · kind B2 · utility
9Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2008 |
| Grant date | Mar 16, 2010 |
| Priority date | — |
| Expiry date | May 19, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a compound of formula (I):Wherein A, l, m, n, R1 and R2 are as defined herein. The compounds of this invention are useful as medicaments, particularly, in the treatment of disorders improved by modulation of the histamine H3 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.